COPENHAGEN (Reuters) – Denmark’s health authority said on Wednesday it expects to announce its decision on how to proceed with Johnson & Johnson’s COVID-19 vaccine next week pending further investigations into its possible link to rare blood clots.
(Reporting by Nikolaj Skydsgaard; Editing by Andrew Heavens)
